These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24304283)

  • 1. Amyloid aggregation inhibitory mechanism of arginine-rich D-peptides.
    Olubiyi OO; Frenzel D; Bartnik D; Glück JM; Brener O; Nagel-Steger L; Funke SA; Willbold D; Strodel B
    Curr Med Chem; 2014; 21(12):1448-57. PubMed ID: 24304283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation.
    Vitalis A; Caflisch A
    J Mol Biol; 2010 Oct; 403(1):148-165. PubMed ID: 20709081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis.
    Leguizamon Herrera VL; Buell AK; Willbold D; Barz B
    ACS Chem Neurosci; 2022 Jun; 13(11):1638-1650. PubMed ID: 35580288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the amyloid β-peptides Aβ1-40 and Aβ1-42 as influenced by pH and a D-peptide.
    Olubiyi OO; Strodel B
    J Phys Chem B; 2012 Mar; 116(10):3280-91. PubMed ID: 22300010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology.
    van Groen T; Schemmert S; Brener O; Gremer L; Ziehm T; Tusche M; Nagel-Steger L; Kadish I; Schartmann E; Elfgen A; Jürgens D; Willuweit A; Kutzsche J; Willbold D
    Sci Rep; 2017 Nov; 7(1):16275. PubMed ID: 29176708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
    Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
    Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Hydrophobicity and Charge of Amyloid-Beta Oligomer Eliminating d-Peptides in the Interaction with Amyloid-Beta Monomers.
    Ziehm T; Buell AK; Willbold D
    ACS Chem Neurosci; 2018 Nov; 9(11):2679-2688. PubMed ID: 29893543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the aggregation mechanism of Aβ(25-40).
    Xiong J; JiJi RD
    Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
    Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
    ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method.
    Boopathi S; Kolandaivel P
    Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite.
    Yu X; Wang Q; Lin Y; Zhao J; Zhao C; Zheng J
    Langmuir; 2012 Apr; 28(16):6595-605. PubMed ID: 22468636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
    Viet MH; Ngo ST; Lam NS; Li MS
    J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of resveratrol to monomer and fibril amyloid beta.
    Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
    Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.